You are here:
| Reference : Fluoxetine therapy in obese diabetic and glucose intolerant patients. |
| Scientific journals : Article | |||
| Human health sciences : Pharmacy, pharmacology & toxicology Human health sciences : Endocrinology, metabolism & nutrition | |||
| http://hdl.handle.net/2268/14024 | |||
| Fluoxetine therapy in obese diabetic and glucose intolerant patients. | |
| English | |
| Kutnowski, M. [> > > >] | |
| Daubresse, J. C. [> > > >] | |
| Friedman, H. [> > > >] | |
| Kolanowski, J. [> > > >] | |
| Krzentowski, G. [> > > >] | |
Scheen, André  [Université de Liège - ULg > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >] | |
| Van Gaal, L. [> > > >] | |
| 1992 | |
| International Journal of Obesity & Related Metabolic Disorders | |
| Nature Publishing Group | |
| 16 Suppl 4 | |
| S63-6 | |
| 0307-0565 | |
| 1476-5497 | |
| London | |
| United Kingdom | |
| [en] Blood Glucose/metabolism ; Diabetes Mellitus/blood/drug therapy/physiopathology ; Double-Blind Method ; Female ; Fluoxetine/adverse effects/therapeutic use ; Glucose Tolerance Test ; Hemoglobin A, Glycosylated/analysis ; Humans ; Hyperglycemia/blood/physiopathology ; Insulin/blood ; Male ; Middle Aged ; Obesity/blood/drug therapy/physiopathology ; Placebos ; Weight Loss | |
| [en] A double-blind placebo-controlled trial was conducted, involving 97 obese diabetic and glucose intolerant patients receiving either 60 mg fluoxetine daily (47 patients) or a placebo (50 patients); a similar calorie-restricted diet was prescribed to all patients. Weight loss was significantly higher in the fluoxetine-treated patients, whose diabetic status improved. Drop-out rate was not significantly different for both groups of patients. | |
| http://hdl.handle.net/2268/14024 |
There is no file associated with this reference.
All documents in ORBi are protected by a user license.
